dactinomycin has been researched along with Lung Diseases, Interstitial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amikura, T; Aoki, Y; Banzai, C; Nishikawa, N; Sekine, M; Suzuki, M; Tanaka, K; Yokoo, T | 1 |
| Beckwith, JB; Breslow, NE; D'Angio, GJ; Finklestein, JZ; Green, DM; Grundy, PE; Haase, GM; Kelalis, PP; Kim, T; Ritchey, ML; Shochat, SJ; Thomas, PR | 1 |
1 trial(s) available for dactinomycin and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Infant; Kidney Neoplasms; Lung Diseases, Interstitial; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Nephrectomy; Vincristine; Wilms Tumor | 1998 |
1 other study(ies) available for dactinomycin and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Metastatic choriocarcinoma successfully treated with paclitaxel and carboplatin after interstitial lung disease induced by EMA-CO.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Liver Neoplasms; Lung Diseases, Interstitial; Lung Neoplasms; Methotrexate; Paclitaxel; Uterine Neoplasms; Vincristine | 2006 |